Robot-Assisted Versus Open Radical Cystectomy: Comparison of Adverse In-Hospital Outcomes
- PMID: 40152714
- DOI: 10.1002/jso.28108
Robot-Assisted Versus Open Radical Cystectomy: Comparison of Adverse In-Hospital Outcomes
Abstract
Purpose: To quantify improvements in adverse in-hospital outcomes between historical and contemporary robot-assisted radical cystectomy (RARC) versus historical and contemporary open RC (ORC).
Material and methods: Within the National Inpatient Sample (2010-2019), RARC and ORC ileal conduit diversion patients were identified. Multivariable logistic and Poisson regression models were fitted.
Results: Of RARC patients, 1343 (39%) were historical (2010-2014) and 2087 (61%) were contemporary (2015-2019). Of ORC patients, 5812 (54%) were historical and 5019 (46%) were contemporary. Versus historical counterparts, contemporary RARC patients exhibited significantly better adverse in-hospital outcomes in 9 of 13 categories, with improvements ranging from -82% for intraoperative complications to -22% for cumulative postoperative complications. Similarly, versus historical, contemporary ORC patients also exhibited significantly better adverse in-hospital outcomes in 9 of 13 categories, with improvements ranging from -72% for intraoperative complications to -12% for median length of stay (LOS). When contemporary RARC was compared to contemporary ORC, RARC adverse in-hospital outcomes were better in 7 of 13 comparisons, with improvements ranging from -55% for blood transfusions to -18% for median LOS. Similarly, when historical RARC was compared to historical ORC, RARC adverse in-hospital outcomes were better in 6 of 13 comparisons, with improvements ranging from -55% for blood transfusions to -15% for median LOS.
Conclusion: The magnitude of the improvement in adverse in-hospital outcomes was comparable between contemporary versus historical RARC (nine improved categories) and contemporary versus historical ORC (nine improved categories). However, contemporary RARC outperformed contemporary ORC in 7 of 13 categories of adverse in-hospital outcomes.
Keywords: NIS; bladder cancer; complications; surgery.
© 2025 Wiley Periodicals LLC.
Similar articles
-
Systematic review and cumulative analysis of perioperative outcomes and complications after robot-assisted radical cystectomy.Eur Urol. 2015 Mar;67(3):376-401. doi: 10.1016/j.eururo.2014.12.007. Epub 2015 Jan 2. Eur Urol. 2015. PMID: 25560798
-
Systematic review and cumulative analysis of oncologic and functional outcomes after robot-assisted radical cystectomy.Eur Urol. 2015 Mar;67(3):402-22. doi: 10.1016/j.eururo.2014.12.008. Epub 2015 Jan 2. Eur Urol. 2015. PMID: 25560797
-
Safety of Robot-Assisted Radical Cystectomy for Muscle-Invasive Bladder Cancer: A Real-World Analysis Using the National Clinical Database in Japan.Cancer Med. 2025 Aug;14(15):e71109. doi: 10.1002/cam4.71109. Cancer Med. 2025. PMID: 40751420 Free PMC article.
-
Comparison of In-Hospital Outcomes at Robot-Assisted Versus Open Partial Nephrectomy.Ann Surg Oncol. 2025 Aug;32(8):6124-6132. doi: 10.1245/s10434-025-17398-3. Epub 2025 May 2. Ann Surg Oncol. 2025. PMID: 40314906
-
Robot-assisted Radical Cystectomy Versus Open Radical Cystectomy: A Systematic Review and Meta-analysis of Perioperative, Oncological, and Quality of Life Outcomes Using Randomized Controlled Trials.Eur Urol. 2023 Oct;84(4):393-405. doi: 10.1016/j.eururo.2023.04.004. Epub 2023 May 9. Eur Urol. 2023. PMID: 37169638
Cited by
-
Costs of robot-assisted vs. open approaches for 5 major cancers.J Robot Surg. 2025 May 7;19(1):205. doi: 10.1007/s11701-025-02350-0. J Robot Surg. 2025. PMID: 40332686
-
Proctoring in robot-assisted urologic surgery: insights from a multicenter survey.J Robot Surg. 2025 Jul 5;19(1):352. doi: 10.1007/s11701-025-02541-9. J Robot Surg. 2025. PMID: 40616608
-
Preoperative CRP is a predictive factor for prolonged hospital stay after radical cystectomy for bladder cancer.BMC Urol. 2025 Jul 9;25(1):162. doi: 10.1186/s12894-025-01847-y. BMC Urol. 2025. PMID: 40634885 Free PMC article.
-
The Effect of Chronic Liver Disease on Adverse In-Hospital Outcomes After Radical Cystectomy and Ileal Conduit Urinary Diversion.Ann Surg Oncol. 2025 Aug 20. doi: 10.1245/s10434-025-18032-y. Online ahead of print. Ann Surg Oncol. 2025. PMID: 40836149
-
Adverse In-hospital Outcomes According to Pelvic Lymph Node Dissection at Partial Cystectomy.Ann Surg Oncol. 2025 Jul 23. doi: 10.1245/s10434-025-17841-5. Online ahead of print. Ann Surg Oncol. 2025. PMID: 40702202
References
-
- T. W. Flaig, P. E. Spiess, M. Abern, et al., “NCCN Guidelines Insights: Bladder Cancer, Version 2.2022,” Journal of the National Comprehensive Cancer Network 20, no. 8 (2022): 866–878, https://doi.org/10.6004/jnccn.2022.0041.
-
- EAU Guidelines on MIBC–DISEASE MANAGEMENT–Uroweb, Uroweb ‐ European Association of Urology. (2024), https://uroweb.org/guidelines/muscle-invasive-and-metastatic-bladder-can....
-
- B. H. Bochner, G. Dalbagni, K. H. Marzouk, et al., “Randomized Trial Comparing Open Radical Cystectomy and Robot‐Assisted Laparoscopic Radical Cystectomy: Oncologic Outcomes,” European Urology 74, no. 4 (2018): 465–471, https://doi.org/10.1016/j.eururo.2018.04.030.
-
- D. J. Parekh, I. M. Reis, E. P. Castle, et al., “Robot‐Assisted Radical Cystectomy Versus Open Radical Cystectomy in Patients With Bladder Cancer (Razor): An Open‐Label, Randomised, Phase 3, Non‐Inferiority Trial,” Lancet 391, no. 10139 (2018): 2525–2536, https://doi.org/10.1016/S0140-6736(18)30996-6.
-
- V. Venkatramani, I. M. Reis, E. P. Castle, et al., “Predictors of Recurrence, and Progression‐Free and Overall Survival Following Open Versus Robotic Radical Cystectomy: Analysis From the RAZOR Trial With a 3‐Year Followup,” Journal of Urology 203, no. 3 (2020): 522–529, https://doi.org/10.1097/JU.0000000000000565.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical